(S)-nicotine decreases expression ISO RGD:1314886 6480464 Nicotine results in decreased expression of FAM107A mRNA CTD PMID:21955143 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression ISO RGD:1605094 6480464 o, p'-DDT results in decreased expression of FAM107A mRNA CTD PMID:19371625 1,1-dichloroethene decreases expression ISO RGD:1314886 6480464 vinylidene chloride results in decreased expression of FAM107A mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression ISO RGD:1314886 6480464 ethylene dichloride results in decreased expression of FAM107A mRNA CTD PMID:28960355 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of FAM107A mRNA CTD PMID:29097150 17beta-estradiol decreases expression ISO RGD:1605094 6480464 Estradiol results in decreased expression of FAM107A mRNA CTD PMID:23019147 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1605094 6480464 Dihydrotestosterone results in increased expression of FAM107A mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1314886 6480464 Tetrachlorodibenzodioxin results in decreased expression of FAM107A mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FAM107A mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1314886 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of FAM107A mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1314886 6480464 Tetrachlorodibenzodioxin affects the expression of FAM107A mRNA CTD PMID:21570461 , PMID:24680724 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:1314886 6480464 3 more ... CTD PMID:19467301 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of FAM107A mRNA CTD PMID:30071829 4,4'-sulfonyldiphenol increases expression ISO RGD:1314886 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FAM107A mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1605094 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in increased methylation of FAM107A gene CTD PMID:31601247 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1605094 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of FAM107A gene CTD PMID:31601247 5-aza-2'-deoxycytidine affects expression ISO RGD:1605094 6480464 Decitabine affects the expression of FAM107A mRNA CTD PMID:23300844 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of FAM107A mRNA CTD PMID:24780913 , PMID:25825206 aflatoxin B1 decreases expression ISO RGD:1314886 6480464 Aflatoxin B1 results in decreased expression of FAM107A mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO RGD:1605094 6480464 Aflatoxin B1 results in increased methylation of FAM107A gene CTD PMID:27153756 arsane decreases expression ISO RGD:1314886 6480464 Arsenic results in decreased expression of FAM107A mRNA CTD PMID:19654921 arsenic atom decreases expression ISO RGD:1314886 6480464 Arsenic results in decreased expression of FAM107A mRNA CTD PMID:19654921 arsenite(3-) increases methylation ISO RGD:1605094 6480464 arsenite results in increased methylation of FAM107A promoter CTD PMID:23974009 benzo[a]pyrene decreases expression ISO RGD:1314886 6480464 Benzo(a)pyrene results in decreased expression of FAM107A mRNA CTD PMID:19770486 benzo[a]pyrene multiple interactions ISO RGD:1314886 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FAM107A mRNA CTD PMID:27858113 benzo[a]pyrene increases expression ISO RGD:1314886 6480464 Benzo(a)pyrene results in increased expression of FAM107A mRNA CTD PMID:21569818 benzo[b]fluoranthene multiple interactions ISO RGD:1314886 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FAM107A mRNA CTD PMID:27858113 beta-hexachlorocyclohexane decreases expression ISO RGD:1314886 6480464 beta-hexachlorocyclohexane results in decreased expression of FAM107A mRNA CTD PMID:25270620 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1605094 6480464 Diethylhexyl Phthalate results in decreased expression of FAM107A mRNA CTD PMID:31163220 bisphenol A decreases expression ISO RGD:1605094 6480464 bisphenol A results in decreased expression of FAM107A mRNA CTD PMID:19371625 bisphenol A decreases methylation ISO RGD:1605094 6480464 bisphenol A results in decreased methylation of FAM107A gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:1605094 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of FAM107A gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:1314886 6480464 bisphenol A results in increased expression of FAM107A mRNA CTD PMID:30951980 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FAM107A mRNA CTD PMID:25181051 more ... bisphenol F affects expression ISO RGD:1314886 6480464 bisphenol F affects the expression of FAM107A mRNA CTD PMID:30951980 buta-1,3-diene increases expression ISO RGD:1314886 6480464 1, 3-butadiene results in increased expression of FAM107A mRNA CTD PMID:29038090 butanal increases expression ISO RGD:1605094 6480464 butyraldehyde results in increased expression of FAM107A mRNA CTD PMID:26079696 carbamazepine affects expression ISO RGD:1605094 6480464 Carbamazepine affects the expression of FAM107A mRNA CTD PMID:25979313 carbon nanotube affects expression ISO RGD:1314886 6480464 Nanotubes, Carbon affects the expression of FAM107A mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1314886 6480464 Nanotubes, Carbon analog results in increased expression of FAM107A mRNA CTD PMID:25554681 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of FAM107A mRNA CTD PMID:23125180 chloroprene increases expression ISO RGD:1314886 6480464 Chloroprene results in increased expression of FAM107A mRNA CTD PMID:23125180 chrysene multiple interactions ISO RGD:1314886 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FAM107A mRNA CTD PMID:27858113 cisplatin affects expression ISO RGD:1605094 6480464 Cisplatin affects the expression of FAM107A mRNA CTD PMID:23300844 clofibrate decreases expression ISO RGD:1314886 6480464 Clofibrate results in decreased expression of FAM107A mRNA CTD PMID:25270620 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of FAM107A mRNA CTD PMID:24386269 copper atom increases expression EXP 6480464 Copper results in increased expression of FAM107A mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of FAM107A mRNA CTD PMID:30556269 crocidolite asbestos decreases expression ISO RGD:1314886 6480464 Asbestos, Crocidolite results in decreased expression of FAM107A mRNA CTD PMID:29279043 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of FAM107A mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO RGD:1314886 6480464 Cyclosporine results in decreased expression of FAM107A mRNA CTD PMID:19770486 dexamethasone increases expression ISO RGD:1314886 6480464 Dexamethasone results in increased expression of FAM107A mRNA CTD PMID:23946490 dexamethasone multiple interactions ISO RGD:1314886 6480464 Valproic Acid inhibits the reaction [Dexamethasone results in increased expression of FAM107A mRNA] CTD PMID:23946490 dibenz[a,h]anthracene increases expression ISO RGD:1314886 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression ISO RGD:1314886 6480464 Dibutyl Phthalate results in decreased expression of FAM107A mRNA CTD PMID:21266533 dichloroacetic acid decreases expression ISO RGD:1314886 6480464 Dichloroacetic Acid results in decreased expression of FAM107A mRNA CTD PMID:28962523 diethylstilbestrol decreases expression ISO RGD:1605094 6480464 Diethylstilbestrol results in decreased expression of FAM107A mRNA CTD PMID:19371625 dorsomorphin multiple interactions ISO RGD:1605094 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions ISO RGD:1314886 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of FAM107A mRNA CTD PMID:21040762 doxorubicin decreases expression ISO RGD:1605094 6480464 Doxorubicin results in decreased expression of FAM107A mRNA CTD PMID:29803840 doxorubicin increases expression ISO RGD:1314886 6480464 Doxorubicin results in increased expression of FAM107A mRNA CTD PMID:21040762 , PMID:28608983 elemental selenium increases expression ISO RGD:1605094 6480464 Selenium results in increased expression of FAM107A mRNA CTD PMID:19244175 Erionite decreases expression ISO RGD:1314886 6480464 erionite results in decreased expression of FAM107A mRNA CTD PMID:29279043 ethanol increases expression ISO RGD:1314886 6480464 Ethanol results in increased expression of FAM107A mRNA CTD PMID:21955143 , PMID:30319688 ethanol affects splicing ISO RGD:1314886 6480464 Ethanol affects the splicing of FAM107A mRNA CTD PMID:30319688 ethanol affects expression ISO RGD:1314886 6480464 Ethanol affects the expression of FAM107A mRNA CTD PMID:30319688 folic acid increases expression ISO RGD:1314886 6480464 Folic Acid results in increased expression of FAM107A mRNA CTD PMID:25629700 fulvestrant multiple interactions ISO RGD:1605094 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in increased methylation of FAM107A gene, [bisphenol A co-treated with Fulvestrant] results in decreased methylation of FAM107A gene CTD PMID:31601247 genistein decreases expression ISO RGD:1605094 6480464 Genistein results in decreased expression of FAM107A mRNA CTD PMID:19371625 manganese atom decreases expression EXP 6480464 Manganese results in decreased expression of FAM107A mRNA CTD PMID:26745496 manganese(0) decreases expression EXP 6480464 Manganese results in decreased expression of FAM107A mRNA CTD PMID:26745496 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of FAM107A mRNA CTD PMID:26745496 medroxyprogesterone acetate increases expression ISO RGD:1605094 6480464 Medroxyprogesterone Acetate results in increased expression of FAM107A mRNA CTD PMID:20843944 methylmercury chloride decreases expression ISO RGD:1605094 6480464 methylmercuric chloride results in decreased expression of FAM107A mRNA CTD PMID:28001369 methylmercury chloride increases expression ISO RGD:1605094 6480464 methylmercuric chloride results in increased expression of FAM107A mRNA CTD PMID:34089799 methylseleninic acid increases expression ISO RGD:1605094 6480464 methylselenic acid results in increased expression of FAM107A mRNA CTD PMID:18548127 morphine increases expression ISO RGD:1314886 6480464 Morphine results in increased expression of FAM107A mRNA CTD PMID:21955143 nevirapine increases expression EXP 6480464 Nevirapine results in increased expression of FAM107A mRNA CTD PMID:23947594 nicotine decreases expression ISO RGD:1314886 6480464 Nicotine results in decreased expression of FAM107A mRNA CTD PMID:21955143 ozone multiple interactions ISO RGD:1314886 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of FAM107A mRNA, [Air Pollutants results in increased abundance of Ozone] which affects the expression of FAM107A mRNA CTD PMID:34911549 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:23829299 phenylmercury acetate multiple interactions ISO RGD:1605094 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM107A mRNA CTD PMID:27188386 poly(I:C) multiple interactions EXP 6480464 [Poly I-C co-treated with HU 211] results in decreased expression of FAM107A mRNA CTD PMID:26923065 progesterone increases expression ISO RGD:1605094 6480464 Progesterone results in increased expression of FAM107A mRNA CTD PMID:17404688 resveratrol decreases expression ISO RGD:1605094 6480464 resveratrol results in decreased expression of FAM107A mRNA CTD PMID:19371625 SB 431542 multiple interactions ISO RGD:1605094 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom increases expression ISO RGD:1605094 6480464 Selenium results in increased expression of FAM107A mRNA CTD PMID:19244175 sodium arsenate increases expression ISO RGD:1314886 6480464 sodium arsenate results in increased expression of FAM107A mRNA CTD PMID:21795629 tamoxifen increases expression ISO RGD:1314886 6480464 Tamoxifen results in increased expression of FAM107A mRNA CTD PMID:25123088 tetrachloromethane increases expression ISO RGD:1314886 6480464 Carbon Tetrachloride results in increased expression of FAM107A mRNA CTD PMID:31919559 tetraphene multiple interactions ISO RGD:1314886 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FAM107A mRNA CTD PMID:27858113 titanium dioxide decreases expression ISO RGD:1314886 6480464 titanium dioxide results in decreased expression of FAM107A mRNA CTD PMID:19464567 tremolite asbestos decreases expression ISO RGD:1314886 6480464 tremolite results in decreased expression of FAM107A mRNA CTD PMID:29279043 trichostatin A decreases expression ISO RGD:1605094 6480464 trichostatin A results in decreased expression of FAM107A mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:1605094 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM107A mRNA CTD PMID:27188386 Triptolide decreases expression ISO RGD:1314886 6480464 triptolide results in decreased expression of FAM107A mRNA CTD PMID:32835833 triptonide increases expression ISO RGD:1314886 6480464 triptonide results in increased expression of FAM107A mRNA CTD PMID:33045310 valproic acid multiple interactions ISO RGD:1314886 6480464 Valproic Acid inhibits the reaction [Dexamethasone results in increased expression of FAM107A mRNA] CTD PMID:23946490 valproic acid multiple interactions ISO RGD:1605094 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM107A mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1605094 6480464 Valproic Acid results in decreased expression of FAM107A mRNA CTD PMID:26272509 vitamin E increases expression ISO RGD:1605094 6480464 Vitamin E results in increased expression of FAM107A mRNA CTD PMID:19244175 vorinostat multiple interactions ISO RGD:1605094 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM107A mRNA CTD PMID:27188386 vorinostat decreases expression ISO RGD:1605094 6480464 vorinostat results in decreased expression of FAM107A mRNA CTD PMID:26272509 zearalenone decreases expression ISO RGD:1605094 6480464 Zearalenone results in decreased expression of FAM107A mRNA CTD PMID:19371625 zoledronic acid increases expression ISO RGD:1605094 6480464 zoledronic acid results in increased expression of FAM107A mRNA CTD PMID:24714768
